SOMERSET, N.J., June 16 /PRNewswire-FirstCall/ -- inVentiv Health, Inc. (Nasdaq: VTIV) today announced that at its Annual Meeting, held Wednesday, June 14, shareholders approved the official change of the Company's name to inVentiv Health, Inc. from Ventiv Health, Inc. Shares of inVentiv Health will continue to trade on NASDAQ under its current symbol "VTIV".

inVentiv Health announced on March 14 that it was changing its corporate brand name as part of a re-branding initiative to reflect the Company's significant expansion and growth and the unique client-focused organization that has been built.

In addition, the Company announced today that all other proposals voted on at the shareholder meeting were also approved by a majority of shareholders. The approved proposals were the re-election of eight incumbent directors of the Company, approval of the Company's 2006 long-term incentive plan, and ratification of Deloitte & Touche LLP as the Company's independent public accounting firm for 2006.

About inVentiv Health

inVentiv Health (Nasdaq: VTIV) is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its three core business segments: inVentiv Clinical, inVentiv Communications and inVentiv Commercial. inVentiv Health currently works with over 175 unique pharmaceutical, biotech and life sciences clients, including all top 20 global pharmaceutical companies. For more information, visit www.inventivhealth.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.

SOURCE inVentiv Health, Inc.